167 related articles for article (PubMed ID: 34213799)
1. Do certified cancer centers provide more cost-effective care? A health economic analysis of colon cancer care in Germany using administrative data.
Cheng CY; Datzmann T; Hernandez D; Schmitt J; Schlander M
Int J Cancer; 2021 Nov; 149(10):1744-1754. PubMed ID: 34213799
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based quality standards improve prognosis in colon cancer care.
Trautmann F; Reißfelder C; Pecqueux M; Weitz J; Schmitt J
Eur J Surg Oncol; 2018 Sep; 44(9):1324-1330. PubMed ID: 29885983
[TBL] [Abstract][Full Text] [Related]
3. Treatment in certified cancer centers is related to better survival in patients with colon and rectal cancer: evidence from a large German cohort study.
Bierbaum V; Bobeth C; Roessler M; Gerken M; Tol KK; Reissfelder C; Fürst A; Günster C; Dröge P; Ruhnke T; Klinkhammer-Schalke M; Schmitt J; Schoffer O
World J Surg Oncol; 2024 Jan; 22(1):11. PubMed ID: 38183134
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Potential of Concentrating Cancer Care in Hospitals With Certification Through Survival Analysis.
Bierbaum V; Schmitt J; Klinkhammer-Schalke M; Schoffer O
Gesundheitswesen; 2023 Sep; 85(S 03):S197-S204. PubMed ID: 37751756
[TBL] [Abstract][Full Text] [Related]
5. Healthcare costs associated with breast cancer in Germany: a claims data analysis.
Kreis K; Plöthner M; Schmidt T; Seufert R; Schreeb K; Jahndel V; Maas S; Kuhlmann A; Zeidler J; Schramm A
Eur J Health Econ; 2020 Apr; 21(3):451-464. PubMed ID: 31897812
[TBL] [Abstract][Full Text] [Related]
6. Health and Economic Impact of Intensive Surveillance for Distant Recurrence After Curative Treatment of Colon Cancer: A Mathematical Modeling Study.
Wanis KN; Maleyeff L; Van Koughnett JAM; H D Colquhoun P; Ott M; Leslie K; Hernandez-Alejandro R; Kim JJ
Dis Colon Rectum; 2019 Jul; 62(7):872-881. PubMed ID: 31188189
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of adding folinic acid to fluorouracil plus levamisole as adjuvant chemotherapy in patients with colon cancer in Germany.
Monz BU; König HH; Leidl R; Staib L; Link KH
Pharmacoeconomics; 2003; 21(10):709-19. PubMed ID: 12828493
[TBL] [Abstract][Full Text] [Related]
8. Estimation of the stage-wise costs of breast cancer in Germany using a modeling approach.
Khan SA; Hernandez-Villafuerte K; Hernandez D; Schlander M
Front Public Health; 2022; 10():946544. PubMed ID: 36684975
[TBL] [Abstract][Full Text] [Related]
9. Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan.
Hsu TC; Chen HH; Yang MC; Wang HM; Chuang JH; Jao SW; Chiang HC; Wen CY; Tseng JH; Chen LT
Value Health; 2011; 14(5):647-51. PubMed ID: 21839401
[TBL] [Abstract][Full Text] [Related]
10. Estimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from Germany.
Haug U; Engel S; Verheyen F; Linder R
PLoS One; 2014; 9(2):e88407. PubMed ID: 24586324
[TBL] [Abstract][Full Text] [Related]
11. Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study.
Roessler M; Schmitt J; Bobeth C; Gerken M; Kleihues-van Tol K; Reissfelder C; Rau BM; Distler M; Piso P; Günster C; Klinkhammer-Schalke M; Schoffer O; Bierbaum V
BMC Cancer; 2022 Jun; 22(1):621. PubMed ID: 35672675
[TBL] [Abstract][Full Text] [Related]
12. The effect of care setting in the delivery of high-value colon cancer care.
Veenstra CM; Epstein AJ; Liao K; Morris AM; Pollack CE; Armstrong KA
Cancer; 2014 Oct; 120(20):3237-44. PubMed ID: 24954628
[TBL] [Abstract][Full Text] [Related]
13. Costs for Colon Cancer Treatment Comparing Benefit Types and Care Sources in the US Military Health System.
Eaglehouse YL; Georg MW; Richard P; Shriver CD; Zhu K
Mil Med; 2019 Dec; 184(11-12):e847-e855. PubMed ID: 30941433
[TBL] [Abstract][Full Text] [Related]
14. Patterns and Drivers of Costs for Neuroendocrine Tumor Care: A Comparative Population-Based Analysis.
Hallet J; Law CHL; Cheung M; Mittmann N; Liu N; Fischer HD; Singh S
Ann Surg Oncol; 2017 Oct; 24(11):3312-3323. PubMed ID: 28695392
[TBL] [Abstract][Full Text] [Related]
15. Real-world cost-effectiveness of laparoscopy versus open colectomy for colon cancer: a nationwide population-based study.
Liao CH; Tan EC; Chen CC; Yang MC
Surg Endosc; 2017 Apr; 31(4):1796-1805. PubMed ID: 27538935
[TBL] [Abstract][Full Text] [Related]
16. Information technology facilitates cost-effectiveness analysis in developing countries: an observational study of breast cancer chemotherapy in Taiwan.
Shih YC; Pan IW; Tsai YW
Pharmacoeconomics; 2009; 27(11):947-61. PubMed ID: 19888794
[TBL] [Abstract][Full Text] [Related]
17. Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan.
Chen PC; Lee JC; Wang JD
PLoS One; 2015; 10(7):e0133755. PubMed ID: 26207912
[TBL] [Abstract][Full Text] [Related]
18. Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.
Mullins CD; Hsiao FY; Onukwugha E; Pandya NB; Hanna N
Cancer; 2012 Jun; 118(12):3173-81. PubMed ID: 22020739
[TBL] [Abstract][Full Text] [Related]
19. The Value of Continuity between Primary Care and Surgical Care in Colon Cancer.
Hussain T; Chang HY; Luu NP; Pollack CE
PLoS One; 2016; 11(5):e0155789. PubMed ID: 27219454
[TBL] [Abstract][Full Text] [Related]
20. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care.
Taplin SH; Barlow W; Urban N; Mandelson MT; Timlin DJ; Ichikawa L; Nefcy P
J Natl Cancer Inst; 1995 Mar; 87(6):417-26. PubMed ID: 7861461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
